Literature DB >> 22430855

Genetics: Personalized medicine and tumour heterogeneity.

Rebecca Kirk.   

Abstract

Entities:  

Year:  2012        PMID： 22430855     DOI： 10.1038/nrclinonc.2012.46

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

2.  Genetic variegation of clonal architecture and propagating cells in leukaemia.

Authors:  Kristina Anderson; Christoph Lutz; Frederik W van Delft; Caroline M Bateman; Yanping Guo; Susan M Colman; Helena Kempski; Anthony V Moorman; Ian Titley; John Swansbury; Lyndal Kearney; Tariq Enver; Mel Greaves
Journal:  Nature       Date:  2010-12-15       Impact factor: 49.962
  2 in total
  11 in total

1.  A Bayesian hidden Potts mixture model for analyzing lung cancer pathology images.

Authors:  Qiwei Li; Xinlei Wang; Faming Liang; Faliu Yi; Yang Xie; Adi Gazdar; Guanghua Xiao
Journal:  Biostatistics       Date:  2019-10-01       Impact factor: 5.899

Review 2.  Building a personalized medicine infrastructure at a major cancer center.

Authors:  Funda Meric-Bernstam; Carol Farhangfar; John Mendelsohn; Gordon B Mills
Journal:  J Clin Oncol       Date:  2013-04-15       Impact factor: 44.544

Review 3.  Technologies for deriving primary tumor cells for use in personalized cancer therapy.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Trends Biotechnol       Date:  2013-04-16       Impact factor: 19.536

Review 4.  Therapeutic potential of mTOR inhibitors for targeting cancer stem cells.

Authors:  Maria Giovanna Francipane; Eric Lagasse
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

Review 5.  Managing Expectations in the Transition to Proof of Concept Studies.

Authors:  Thomas Kieber-Emmons; Issam Makhoul; Angela Pennisi; Eric R Siegel; Peter D Emanuel; Bejotaloh Monzavi-Karbassi; Zenon Steplewski; J Thaddeus Beck; Laura F Hutchins
Journal:  Rev Recent Clin Trials       Date:  2017

Review 6.  The case for AI-driven cancer clinical trials - The efficacy arm in silico.

Authors:  Likhitha Kolla; Fred K Gruber; Omar Khalid; Colin Hill; Ravi B Parikh
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-05-31       Impact factor: 11.414

7.  Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories.

Authors:  Toshihide Nishimura; Takeshi Kawamura; Yutaka Sugihara; Yasuhiko Bando; Shigeru Sakamoto; Masaharu Nomura; Norihiko Ikeda; Tatsuo Ohira; Junichiro Fujimoto; Hiromasa Tojo; Takao Hamakubo; Tatsuhiko Kodama; Roland Andersson; Thomas E Fehniger; Harubumi Kato; György Marko-Varga
Journal:  Clin Transl Med       Date:  2014-11-22

8.  Relationships of Ex-Vivo Drug Resistance Assay and Cytokine Production with Clinicopathological Features in the Primary Cell Culture of Thai Ovarian and Fallopian Tube Cancer Patients

Authors:  May Thuu Mon; Supachai Yodkeeree; Wanisa Punfa; Sonthaya Umsumarng; Suree Lekwanavijit; Sumalee Siriaunkgul; Prapaporn Suprasert; Pornngarm Limtrakul
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

9.  Specific and sensitive tumor imaging using biostable oligonucleotide aptamer probes.

Authors:  Zihua Zeng; Parag Parekh; Zheng Li; Zheng-Zheng Shi; Ching-Hsuan Tung; Youli Zu
Journal:  Theranostics       Date:  2014-07-19       Impact factor: 11.556

10.  Loperamide, an antidiarrheal agent, induces apoptosis and DNA damage in leukemia cells.

Authors:  Xin He; Lei Zhu; Shu Li; Zhigang Chen; Xiaoying Zhao
Journal:  Oncol Lett       Date:  2017-11-17       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.